Separately do 2 year cross section analysis graph like below and findings/analysis for the 2 ratios of Beacon Pharma

Transcribed Image Text:

Cross Section Analysis: 0.66 0.65 Total Asset Turnover 0.64 0.63 0.62 0.62 0.61 0.6 2013 0.65 0.64 2014 2015 From the industry benchmark we found 2013 it was0 .62, 2014 it was 0.65 and 0.64 in 2015 which means every consecutive year Beximco was lagging behind benchmark and so the company was able to generate sales. Cross Section Analysis: 0.66 0.65 Total Asset Turnover 0.64 0.63 0.62 0.62 0.61 0.6 2013 0.65 0.64 2014 2015 From the industry benchmark we found 2013 it was0 .62, 2014 it was 0.65 and 0.64 in 2015 which means every consecutive year Beximco was lagging behind benchmark and so the company was able to generate sales.